US 9624184
Heterocyclic compound
granted A61PA61P25/00A61P25/08
Quick answer
US patent 9624184 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61P, A61P25/00, A61P25/08, A61P25/14, A61P25/16